← Back to Search

Cardiovascular Rehabilitation for Heart Disease

N/A
Recruiting
Research Sponsored by Laval University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Any individual aged 18 years and older who has been diagnosed with peripheral artery disease, coronary artery disease, angina, ischemic heart failure, transient ischemic attack or ischemic stroke (non-cardioembolic, non-hemorrhagic)
Be older than 18 years old
Must not have
Being not able to give written informed consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to 12 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to study the changes in blood flow in the feet of patients with heart, brain, or leg artery diseases who are participating in a 12-week rehabilitation program. The study will also look

Who is the study for?
This trial is for individuals with various heart and blood vessel conditions like coronary artery disease, stroke, or peripheral arterial disease. Participants should be referred to a 12-week cardiovascular rehabilitation program.
What is being tested?
The study aims to observe changes in blood flow in the forefoot of patients with vascular diseases after they complete a specialized 12-week heart health improvement program.
What are the potential side effects?
Since this trial involves a non-invasive rehabilitation program rather than medication, side effects are minimal but may include exercise-related discomfort or fatigue.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 or older with a diagnosis of heart or artery disease.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am unable to provide written consent.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in toe pressure measurement
Secondary study objectives
Change in 6-minute walk test (6MWT)
Short Form Health Survey 36 (SF-36)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Cardiovascular rehabilitation programExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Laval UniversityLead Sponsor
434 Previous Clinical Trials
178,558 Total Patients Enrolled
CISSS de Chaudière-AppalachesOTHER_GOV
8 Previous Clinical Trials
16,379 Total Patients Enrolled
~53 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top